{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T10:58:59Z","timestamp":1764586739934},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IAD"],"published-print":{"date-parts":[[2010,6,1]]},"DOI":"10.2174\/187221310791163080","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T23:49:47Z","timestamp":1271980187000},"page":"159-176","source":"Crossref","is-referenced-by-count":5,"title":["Intestinal Permeability as a Clinical Surrogate Endpoint in the Development of Future Crohn's Disease Therapies"],"prefix":"10.2174","volume":"4","author":[{"given":"Xiaonan","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Recent Patents on Inflammation & Allergy Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/93820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:24:29Z","timestamp":1448288669000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1872-213X&volume=4&issue=2&spage=159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/187221310791163080","relation":{},"ISSN":["1872-213X"],"issn-type":[{"value":"1872-213X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}